MeCure is a leading human therapeutics company in the pharmaceutical industry in Lagos, Nigeria.
Quality is the core of everything we do. Our commitment to cGMP standards and ISO 9001:2015 certification reflects our dedication to delivering medicines that are safe, effective, and of the highest possible quality. Every product undergoes rigorous quality control processes to ensure it meets global standards.
Innovation is at the heart of MeCure. We constantly invest in research and development to bring pioneering solutions to the healthcare industry. Whether it’s developing new drug formulations or optimizing delivery systems, we strive to improve healthcare access and outcomes through groundbreaking advancements.
We are driven by the belief that quality healthcare should be accessible to all. Our focus on affordability without compromising quality is part of our commitment to make essential healthcare products available across Nigeria and West Africa. By addressing common healthcare challenges, we aim to meet the needs of underserved communities.
Our people are integral to our success. At MeCure, we cultivate a culture of integrity, accountability, and growth, empowering our team to make a positive impact. Our employees embody our mission to enhance lives, driving us forward with dedication and purpose.
Our extensive range of over-the-counter products offers safe and effective solutions for everyday health needs. From pain relief to cold and flu remedies, each OTC medicine undergoes rigorous testing to ensure quality and efficacy, making healthcare more accessible and manageable for individuals.
We provide essential, affordable medicines that maintain the high standards of their brand-name counterparts. Our generics, including key antibiotics like Amoxiclav and Ampiclox, are developed to meet the healthcare needs of a broad population. Each product adheres to stringent quality standards, ensuring effectiveness and reliability.
Our dietary supplements, such as Zevit multivitamins, are formulated to support overall wellness by addressing essential nutritional needs. Designed for people of all ages, these supplements promote balanced health, ensuring that individuals can lead healthier, more vibrant lives.
Lagos, Nigeria – In a year marked by economic pressures, MeCure Industries PLC has managed to grow its revenue significantly, closing 2024 with ₦46.03 billion, a 45% increase from the previous year. Despite inflation, currency devaluation, and rising production costs, the company strengthened its market position through increased local manufacturing and better distribution strategies.
Learn More
January 23, 2024
We are excited to announce the launch of our new grant program aimed at support...
Learn More
January 23, 2024
In our latest blog feature, we highlight the incredible work of local hero Jane...
Learn MoreHowever, the growth came with its own set of challenges. Operating costs rose sharply, with marketing and administrative expenses increasing by 59%. Rising interest rates also pushed finance costs to ₦4.98 billion, more than double the previous year. As a result, net profit dropped by 20% to ₦2.33 billion. The company’s borrowings also grew to ₦36.17 billion as it continued to invest in expansion.
Still, MeCure remained focused on making quality medicines more accessible. Sales across its key product categories performed well, and the company’s investments in supply chain efficiency helped it navigate the tough environment. Looking ahead, MeCure plans to manage costs more effectively, boost manufacturing efficiency, and improve financial stability while continuing to serve the healthcare needs of Nigerians.
